| Name | Company | Title | Industry | Location | Country | |
|---|---|---|---|---|---|---|
| Jeffrey Trigilio | jtr******@cullinanoncology.com | cullinanoncology.com | Chief Financial Officer | New York, NY, US | ||
| Karsten Sauer | ksa***@cullinanoncology.com | cullinanoncology.com | Vice President, Preclinical R and D | Cambridge, MA, US | ||
| Jennifer Michaelson | jmi********@cullinanoncology.com | cullinanoncology.com | Chief Scientific Officer | Boston, Massachusetts, United States | ||
| Sal Firicano | sfi******@cullinanoncology.com | cullinanoncology.com | VP and Head of Information Technology | Melrose, MA, US | ||
| Phill Gallacher | pga*******@cullinanoncology.com | cullinanoncology.com | VP, Clinical Development Operations and Clinical Program Management | Boston, MA, US | ||
| Mark Melville | mme******@cullinanoncology.com | cullinanoncology.com | Vice President of Cmc, Biologics | Melrose, MA, US | ||
| Jeffrey Jones | jjo***@cullinanoncology.com | cullinanoncology.com | New York, NY, US | |||
| Chad Messer | cme****@cullinanoncology.com | cullinanoncology.com | Vice President of Investor Relations | New York, NY, US | ||
| Brian Stuglik | bst*****@verastem.com | verastem.com | Chief Executive Officer | United States | ||
| Jonathan Pachter | jpa*****@verastem.com | verastem.com | Chief Scientific Officer | Boston, MA, US |